Cascadia Capital, an investment bank serving middle market clients globally, today announced it acted as the exclusive financial advisor to Retina Consultants of Southern Colorado (“RCSC”) in its acquisition by Retina Consultants of America (“RCA”), a comprehensive physician management services organization. With six board-certified physicians and three clinic locations, RCSC’s partnership bolsters RCA’s Colorado footprint and furthers its influence in innovative retina research across the U.S. RCA now has a total network of more than 235 physicians across more than 300 locations.
Established in 1987, RCSC physicians specialize in the treatment of retinal diseases, laser procedures and surgery, using state-of-the-art diagnostic testing equipment, lasers, surgical instruments, research, and studies to further enhance each diagnosis, condition, and treatment. In addition to delivering exceptional patient care, RCSC’s renowned team of physicians are recognized leaders for their publications and participation in retinal research and clinical trials. Together with RCA, the physicians, and dedicated staff of RCSC look forward to continuing their involvement in groundbreaking clinical studies in an effort to ensure patients receive the latest innovative procedures and therapies.
“Retina Consultants of Southern Colorado is thrilled to partner with RCA to achieve synergy in providing the highest quality and most technologically advanced retina care along with many of the most prestigious, innovative, and forward-thinking practices in the nation,” said Adam Martidis, M.D., Retina Consultants of Southern Colorado.
“Cascadia was pivotal in securing a highly successful outcome in the acquisition of our medical practice,” continued Dr. Martidis. “Their actions and guidance can best be described as smart, strategic, patient, and efficient. There is no way we could have achieved the outstanding result in our deal without their unparalleled professionalism, strict attention to detail, and stellar advocacy.”
“Cascadia is pleased to have played a part in orchestrating a transaction uniting two exceptionally driven parties,” said Vitaliy Marchenko, Cascadia Director. “We are excited to have helped pave the way for this remarkable outcome and an even more promising future partnership.”
Physician partnership and consolidation has become one of the dominant recent trends in the healthcare landscape. Cascadia has been a key advisor to clinics and doctors interested in exploring or taking advantage of this market dynamic. Our team has worked with retina, ophthalmology, gastroenterology, fertility, dermatology, cardio and vascular, and many other physicians interested in exploring strategic opportunities.
This acquisition represents another successful transaction for Cascadia in the healthcare services and physician practice management sector.
Past transactions include: